SCHEMBL308477

SCHEMBL308477

c1ccc(-n2c3ccccc3c3cc(-c4ccc(-c5nc6ccccc6o5)cc4)ccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ATM Q13315 2/20 0.48
▸ KDM4E B2RXH2 5/20 0.45
▸ HPGD P15428 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ HSD17B10 Q99714 4/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TP53 P04637 2/20 0.45
▸ MAPT P10636 3/20 0.44
▸ USP2 O75604 2/20 0.44
▸ HCRTR1 O43613 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065313 1.00 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL10065323 1.00 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL19846147 0.98 NPC1 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL10065178 0.96 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL10065366 0.96 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL308089 0.96 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL10065374 0.96 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL10065282 0.96 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM
SCHEMBL22747032 0.96 NPC1 (0.46) NPC1RAB9AMEN1KMT2AATM
SCHEMBL10065286 0.96 NPC1 (0.48) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10167303-B2 Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex UDC IRELAND LIMITED (IE) 2019-01-01 — — US disclosed
EP-2802594-B1 METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES UDC IRELAND LTD (IE) 2017-04-19 — — EP disclosed
US-20170044194-A1 Metal Complexes with Dibenzo[f,h]quinoxalines UDC IRELAND LTD (IE) 2017-02-16 — — US disclosed
US-20170044194-A1 Metal Complexes with Dibenzo[f,h]quinoxalines UDC IRELAND LTD (IE) 2017-02-16 — — US disclosed
US-9472762-B2 Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex UDC IRELAND LIMITED (IE) 2016-10-18 — — US disclosed
US-9472762-B2 Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex UDC IRELAND LIMITED (IE) 2016-10-18 — — US disclosed
US-20150005497-A1 METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES BASF SE (DE) 2015-01-01 — — US disclosed
US-20150005497-A1 METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES BASF SE (DE) 2015-01-01 — — US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
WO-2013104649-A1 METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES BASF SE (DE) 2013-07-18 — — WO disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10167303-B2 Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex NDUFS5, DDT, NDUFV2 NPC1 4669/4885RAB9A 1151/4885MEN1 1212/4885
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative GABRA1, GABRA4, GABRA5 NPC1 4146/4885RAB9A 2525/4885MEN1 3301/4885
US-20170044194-A1 Metal Complexes with Dibenzo[f,h]quinoxalines NDUFS2, OCIAD2, NDUFS3 NPC1 3696/4885RAB9A 717/4885MEN1 2679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback